Ferroportin Depletes Iron Needed for Cell Cycle Progression in Head and Neck Squamous Cell Carcinoma
This study shows that FPN depletion causes iron deficiency in HNSCC cells, inhibiting proliferation and promoting senescence, suggesting iron-based therapies could target HNSCC.
bioRxiv · Aug 26, 2022Cancer Biology